David Goodman-Meza, Steven Shoptaw, Brett Hanscom, Laramie R Smith, Philip Andrew, Irene Kuo, Jordan E Lake, David Metzger, Ellen A B Morrison, Melissa Cummings, Jessica M Fogel, Paul Richardson, Jayla Harris, Jesse Heitner, Sarah Stansfield, Nabila El-Bassel
BACKGROUND: Persons with opioid use disorders who inject drugs (PWID) in the United States (US) face multiple and intertwining health risks. These include interference with consistent access, linkage, and retention to health care including medication for opioid use disorder (MOUD), HIV prevention using pre-exposure prophylaxis (PrEP), and testing and treatment for sexually transmitted infections (STIs). Most services, when available, including those that address substance misuse, HIV prevention, and STIs, are often provided in multiple locations that may be difficult to access, which further challenges sustained health for PWID...
February 15, 2024: Trials